Table 1.
| EMD | PDGF-BB | FGF-2 | BMP-2 and -7 | |
|---|---|---|---|---|
| Endogenous sources | Hertwig’s epithelial root sheath | BB isoform: osteoblasts, macrophages & endothelial cells. Only AB isoform is derived from platelets and found in blood. | Macrophages & endothelial cells | Osteoblasts & bone matrix |
| Composition | > 90% amgelogenin, Small % ameloblastin, fetuin A & α-1-antichymotrypsin | Protein | Protein | Protein |
| Mechanism of action | Exact MOA unknown. Believed to play a role in cementogenesis. | ↑ chemotaxis of PMNs & monocytes, ↑ endothelial cell chemotaxis, proliferation & differentiation, ↑ fibroblast proliferation & ECM synthesis |
↑ fibroblast proliferation & ECM synthesis ↑ endothelial cell chemotaxis, proliferation & differentiation ↑ mesenchymal progenitor cell migration |
BMP-2: ↑ mesenchymal osteoprogenitor cell migration BMP-7: ↑ osteoblast and chondroblast differentiation |
| FDA approval (Labelled usage) | Yes (intrabony, class 2 furcation defects & gingival recession coverage) | Yes (intrabony defects, furcations, gingival recession) | No | BMP-2: Yes (sinus augmentation, socket preservation) BMP-7: No for dental usage; approved for spinal fusion & long bone non-union treatment |
| Preclinical and clinical evidence for other usages | Clinical evidence for treatment of peri-implantitis-associated defects[20–22] | Clinical evidence for GBR[41,149] and peri-implantitis-associated defects[150] | Clinical evidence for intrabony defects[57]; pre-clinical evidence for peri-implant defects[151] | Clinical evidence for GBR and pre-clinical evidence for peri-implantitis-associated defects[67,77] |
| Commercial products | Emdogain (Straumann) | GEM 21S (Lynch Biologics) | None yet | BMP-2: Infuse Bone Graft (Medtronic) BMP-7: Osigraft (Stryker Biotech) |
↑: increased; EMD: enamel matrix derivative; rhPDGF-BB: recombinant human platelet-derived growth factor-BB; FGF: fibroblast growth factor; BMP: bone morphogenetic protein; PMN: polymorphonuclear leukocyte; ECM: extracellular matrix; FDA: Food and Drug Administration; GBR: guided bone regeneration